Stock ATRY ATRYS HEALTH, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Atrys Health, S.A.

Equities

ATRY

ES0105148003

Healthcare Facilities & Services

Market Closed - BME
Other stock markets
 11:35:26 2024-04-26 am EDT 		5-day change 1st Jan Change
2.88 EUR -0.35% Intraday chart for Atrys Health, S.A. -2.37% -21.53%
Mar. 26 Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Atrys Health, S.A. announced that it has received ?13.3 million in funding CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 113.2 298.6 621 456.6 278.4 218.7 - -
Enterprise Value (EV) 1 112 341 695.8 574.1 278.4 373.9 339.7 218.7
P/E ratio -1,000 x -125 x -22.1 x -18.2 x -6.11 x -66.8 x 25 x -
Yield - - - - - - - -
Capitalization / Revenue 7.63 x 9.51 x 5.13 x 2.44 x 1.38 x 0.98 x 0.91 x 0.84 x
EV / Revenue 7.55 x 10.9 x 5.75 x 3.07 x 1.38 x 1.68 x 1.42 x 0.84 x
EV / EBITDA 21.9 x 57.5 x 120 x 25.9 x 6.54 x 7.97 x 6.2 x -
EV / FCF - -7.73 x -180 x - - 11.7 x 12 x -
FCF Yield - -12.9% -0.56% - - 8.53% 8.3% -
Price to Book 3.2 x 4.09 x 2.27 x 1.39 x - 0.76 x 0.56 x -
Nbr of stocks (in thousands) 22,632 33,545 61,178 73,638 75,851 75,934 - -
Reference price 2 5.000 8.900 10.15 6.200 3.670 2.880 2.880 2.880
Announcement Date 3/31/20 4/27/21 3/30/22 3/29/23 3/26/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 14.84 31.4 121 187 201.6 222.7 239.5 261
EBITDA 1 5.11 5.932 5.783 22.14 42.59 46.93 54.8 -
EBIT 1 1.215 5.673 -15 -8.204 12.92 14.51 29.8 29
Operating Margin 8.19% 18.07% -12.4% -4.39% 6.41% 6.51% 12.44% 11.11%
Earnings before Tax (EBT) 1 0.2066 -1.309 -24.88 -24.69 -33.7 -4.194 6 20
Net income 1 - -2.015 -23.26 -23.26 -45.59 -0.9399 8.35 -
Net margin - -6.42% -19.22% -12.44% -22.62% -0.42% 3.49% -
EPS 2 -0.005000 -0.0710 -0.4600 -0.3410 -0.6010 -0.0431 0.1150 -
Free Cash Flow 1 - -44.08 -3.873 - - 31.9 28.2 -
FCF margin - -140.41% -3.2% - - 14.32% 11.77% -
FCF Conversion (EBITDA) - - - - - 67.98% 51.46% -
FCF Conversion (Net income) - - - - - - 337.72% -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/31/20 4/27/21 3/30/22 3/29/23 3/26/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 S2 2023 S1 2023 S2
Net sales - - - -
EBITDA 1 17.38 - 22.65 16.85
EBIT 1 -0.091 -8.113 5.779 4.054
Operating Margin - - - -
Earnings before Tax (EBT) -4.379 -20.31 - -
Net income 1 -3.166 -20.09 -23 -22.59
Net margin - - - -
EPS - - - -
Dividend per Share - - - -
Announcement Date 9/30/22 3/29/23 9/29/23 3/26/24
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 42.4 74.9 118 - 155 121 -
Net Cash position 1 1.19 - - - - - - -
Leverage (Debt/EBITDA) - 7.148 x 12.95 x 5.309 x - 3.308 x 2.208 x -
Free Cash Flow 1 - -44.1 -3.87 - - 31.9 28.2 -
ROE (net income / shareholders' equity) 5.68% -3.5% -13.5% -7.61% - -0.29% 3.65% -
ROA (Net income/ Total Assets) - 1.32% - -3.66% - - 0.7% -
Assets 1 - -152.8 - 635.5 - - 1,193 -
Book Value Per Share 2 1.560 2.170 4.470 4.450 - 3.780 5.130 -
Cash Flow per Share 2 0.0500 0.2800 0.0900 -0.2300 - 0.3400 - -
Capex 1 - 52.1 8.57 15.2 - 17 13 -
Capex / Sales - 165.89% 7.08% 8.11% - 7.63% 5.43% -
Announcement Date 3/31/20 4/27/21 3/30/22 3/29/23 3/26/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Atrys Health, S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.88 EUR
Average target price
6.61 EUR
Spread / Average Target
+129.51%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
ATRYS HEALTH, S.A. Stock Atrys Health, S.A.
-21.53% 233M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. ATRY Stock
  4. Financials Atrys Health, S.A.